Respiratory infection raises anticoagulation risk in people taking warfarin

01/21/2014 | MedPage Today (free registration)

Patients with acute upper respiratory tract infections who take warfarin had a more than twofold higher risk of excessive anticoagulation, regardless of whether they were treated with antibiotics, according to a study in JAMA Internal Medicine. However, the risk of developing excessive anticoagulation was significantly higher among those taking metronidazole, trimethoprim-sulfamethoxazole, or other antibiotics that interfere with the body's processing of warfarin.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Fremont, CA